SecBot SecBot

NXL

Nexalin Technology, Inc.
Nasdaq· Electromedical & Electrotherapeutic Apparatus· Inc. DE· CIK 0001527352 Healthcare & Medical Devices
$1.64 −0.07 (−4.09%)
Oct 27 4:00 PM ET · prev $1.71
Market cap
$2.0M
Nano cap
Median target
$15.00
+815% · range $15.00–15.00
Next earnings
Nov 12
in 16 days · EPS est. −$2.91
1 year
−96.3%
from $44.40 · Oct 27
30 days
−61.6%
from $4.27
52-week range
$1.64–46.50
at the low
Avg volume 20D
3.28M
Oct 1 spike 62.34M
Short interest
🔒 Subscribers only
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
11
analyzed by SecBot
SecBot read BEARISH 7 reports · 90 days
Balance 3 bearish · 1 bullish · 1 mixed · 2 neutral oldest → newest, height = score
Avg score ·High conf. 7/7 ·Next Earnings date, Nov 12, 2026
Strongest BEARISH Nexalin Technology filed Amendment No. 1 to its S-1 registration statement to register up to 5,752,823…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 2 trimmed or exited.

  • EstimatesFALLING

    Current-quarter EPS estimate −$2.700 → −$2.910 over 90 days.

  • TrendDOWNTREND

    68% below its 50-day average. New closing low $1.64 on Oct 27.

  • SocialQUIET

    No Reddit mentions this week. Last mention Oct 2.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
PEAK6 LLCTRIM240,210$79.3K
GEODE CAPITAL MANAGEMENT, LLCTRIM139,583$46.1K
JANE STREET GROUP, LLCDOUBLED65,497$21.6K
GEODE CAPITAL MANAGEMENT, LLCADD247,037$86.0K
UBS Group AGADD22,189$7.7K
RENAISSANCE TECHNOLOGIES LLCNEAR_EXIT10,676$3.7K
JANE STREET GROUP, LLCTRIM10,510$3.7K
FMR LLCNEAR_EXIT1,500$522.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Mar 2025
12-month targets · 1 analysts

Price is below the lowest target. Median implies +815%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Mar 24, 2025Maxim Group
UPGRADE
UPGRADEBuy
Dec 5, 2024Maxim Group
DOWNGRADE
DOWNGRADEHold
Oct 9, 2024Maxim Group
INITIATE
INITIATEBuy

Washington

Corporate Lobbying

8 lobbying filings and 6 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Earnings setup

Estimates
Nov 12
reports in 16 days
−$2.91
EPS estimate, this quarter
−8%
estimate change, 90 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$2.91-$2.91–-$2.91-7.8%$75.0K
Next Q-$2.34-$2.34–-$2.34+13.3%$90.0K
Current FY-$11.42-$11.42–-$11.42-0.2%$192.0K
Next FY-$7.55-$7.55–-$7.55+18.8%$338.0K
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 16, 2026 SEC
Nexalin Technology's S-1 registration statement (File No. 333-298744) was declared effective by the SEC on October 15…
EFFECT — Impact 6/10
Oct 8, 2026 SEC
Nexalin Technology filed Amendment No. 1 to its S-1 registration statement to register up to 5,752,823 shares for…
S-1/A — Impact 7/10
Oct 5, 2026 Trading halt
Halt Resumed: NXL — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-05T16:43:57.000Z | Resumed 2026-10-05T16:48:57.000Z
Oct 1, 2026 SEC
Nexalin Technology received formal notification from Nasdaq on September 30, 2026, confirming it has regained…
8-K — Impact 6/10
Jun 30, 2026 Inst.
PEAK6 LLC — TRIM
240,210 shares ($79.3K)
Jun 30, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC — TRIM
139,583 shares ($46.1K)
Jun 10, 2026 Press
Nexalin announced positive results from an open-label pilot trial of its DIFS 15mA/77.5Hz neurostimulation platform in…
Impact 7/10
May 19, 2026 Press
Nexalin Technology closed the $1.3M acquisition of PONM, Inc. and entered an exclusive license and strategic…
Impact 6/10

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Trading halts
Oct 5, 2026Volatility PauseResumed
Oct 1, 2026Volatility PauseResumed
Oct 1, 2026Volatility PauseResumed
Oct 1, 2026Volatility PauseResumed
Oct 1, 2026Volatility PauseResumed
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 12, 2026
Earnings date
NXL Q3 2026 Earnings Scheduled — 2026-11-12
Recent
Oct 5, 2026
Trading halt
Halt Resumed: NXL — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-05T16:43:57.000Z | Resumed 2026-10-05T16:48:57.000Z
Oct 5, 2026
Trading halt
Trading Halt: NXL — LUDP (Volatility Trading Pause)
Nexalin Technology, Inc Cm Stk | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Oct 1, 2026
Trading halt
Halt Resumed: NXL — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-01T14:24:44.000Z | Resumed 2026-10-01T14:29:44.000Z
Oct 1, 2026
Trading halt
Trading Halt: NXL — LUDP (Volatility Trading Pause)
Nexalin Technology, Inc Cm Stk | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Oct 1, 2026
Trading halt
Halt Resumed: NXL — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-01T14:06:33.000Z | Resumed 2026-10-01T14:16:34.000Z
Reddit
Recent posts
r/pennystocks Neutral 25d ago
02 OCT 2026 , WHAT ARE THE BIGGEST LOSERS AND WHY ?
1 upvotes · 1 comments
All social signals and their track records

SecBot reports

11 filings · 2 press releases · 1 bullish · 4 bearish · 2 mixed · 4 neutral
All NXL filing & press-release reports (13)